Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017032897) USE OF BIFIDOBACTERIUM LONGUM AND AN EXOPOLYSACCHARIDE PRODUCED THEREBY
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/032897 International Application No.: PCT/EP2016/070253
Publication Date: 02.03.2017 International Filing Date: 26.08.2016
IPC:
A61P 37/08 (2006.01) ,A61K 31/716 (2006.01) ,A61P 11/06 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37
Drugs for immunological or allergic disorders
08
Antiallergic agents
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
715
Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
716
Glucans
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
11
Drugs for disorders of the respiratory system
06
Antiasthmatics
Applicants:
ALIMENTARY HEALTH LIMITED [IE/IE]; Building 4400, Cork Airport Business Park, Kinsale Road, Cork, T12 N84F, IE
Inventors:
O'MAHONY, Liam; IE
PLATTNER, Stephan; IE
ALTMANN, Friedrich; AT
KOSMA, Paul; AT
Agent:
O'BRIEN, John; IE
WELDON, Michael; IE
Priority Data:
15182694.827.08.2015EP
15182695.527.08.2015EP
Title (EN) USE OF BIFIDOBACTERIUM LONGUM AND AN EXOPOLYSACCHARIDE PRODUCED THEREBY
(FR) UTILISATION DE BIFIDOBACTERIUM LONGUM ET EXOPOLYSACCHARIDE PRODUIT ASSOCIÉ
Abstract:
(EN) Prophylaxis or treatment of allergic airway inflammatory activity is described using Bifidobacterium longum NCIMB 41003. Also described is an exopolysaccharide which comprises the structure Formula (I). The polysaccharide may be used for treating or preventing undesirable inflammatory activity.
(FR) L'invention concerne l'utilisation de Bifidobacterium longum NCIMB 41003 pour la prophylaxie ou le traitement d'une activité inflammatoire allergique des voies aériennes. L'invention concerne également un exopolysaccharide de formule structurelle (I). Le polysaccharide peut être utilisé pour traiter ou prévenir une activité inflammatoire indésirable.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)